Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Shanghai - Delayed Quote CNY

Obio Technology (Shanghai) Corp., Ltd. (688238.SS)

5.83
-0.06
(-1.02%)
At close: 3:00:03 PM GMT+8
Currency in CNY All numbers in thousands
Download
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
248,149.23
248,149.23
204,805.01
291,304.28
254,949.06
Cost of Revenue
341,969.51
341,969.51
217,859.60
161,931.98
124,069.13
Gross Profit
-93,820.28
-93,820.28
-13,054.59
129,372.30
130,879.93
Operating Expense
167,415.34
167,415.34
143,171.56
114,357.39
80,824.50
Operating Income
-261,235.63
-261,235.63
-156,226.15
15,014.91
50,055.43
Net Non Operating Interest Income Expense
-190.96
-190.96
16,232.05
27,512.45
8,211.13
Pretax Income
-312,627.12
-312,627.12
-155,603.61
41,624.19
60,784.62
Tax Provision
9,555.23
9,555.23
-27,789.91
2,367.73
6,527.32
Net Income Common Stockholders
-321,813
-321,813
-127,938.33
39,256.46
54,257.30
Basic EPS
-0.50
-0.50
-0.20
0.07
0.11
Diluted EPS
-0.50
-0.50
-0.20
0.07
0.11
Basic Average Shares
647,511.07
647,511.07
642,906.18
603,945.51
511,119.49
Diluted Average Shares
647,511.07
647,511.07
642,906.18
603,945.51
511,119.49
Total Operating Income as Reported
-310,450.81
-310,450.81
-155,446.01
41,708.05
60,796.87
Rent Expense Supplemental
1,663.72
1,663.72
3,033.44
1,924.62
3,358.85
Total Expenses
509,384.85
509,384.85
361,031.16
276,289.37
204,893.63
Net Income from Continuing & Discontinued Operation
-321,813
-321,813
-127,938.33
39,256.46
54,257.30
Normalized Income
-285,194.16
-285,194.16
-116,233.89
42,143.33
55,181.92
Interest Income
7,321.39
7,321.39
23,112.14
30,390.93
11,247.97
Interest Expense
7,454.79
7,454.79
6,829.50
2,762.42
2,975.78
Net Interest Income
-190.96
-190.96
16,232.05
27,512.45
8,211.13
EBIT
-305,172.32
-305,172.32
-148,774.11
44,386.61
63,760.40
EBITDA
-219,867.17
-219,867.17
-114,429.23
69,510.65
83,744.46
Reconciled Cost of Revenue
341,969.51
341,969.51
217,859.60
161,931.98
124,069.13
Reconciled Depreciation
85,305.15
85,305.15
34,344.88
25,124.04
19,984.06
Net Income from Continuing Operation Net Minority Interest
-321,813
-321,813
-127,938.33
39,256.46
54,257.30
Total Unusual Items Excluding Goodwill
-48,825.13
-48,825.13
-14,249.28
-3,060.99
-1,035.86
Total Unusual Items
-48,825.13
-48,825.13
-14,249.28
-3,060.99
-1,035.86
Normalized EBITDA
-171,042.04
-171,042.04
-100,179.96
72,571.65
84,780.32
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
-12,206.28
-12,206.28
-2,544.84
-174.12
-111.24
12/31/2021 - 3/22/2022

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

OBIO Orchestra BioMed Holdings, Inc.
2.8600
+0.70%
 
WINTW WINDTREE THERAPEUTICS INC C/WTS
0.0070
+100.00%
 
MLEC Moolec Science SA
0.6801
-1.15%
 
INNMF Amplia Therapeutics Limited
0.0310
0.00%
 
PBMWW Psyence Biomedical Ltd.
0.0148
+29.82%
 
PMN ProMIS Neurosciences, Inc.
0.6088
+7.37%
 
388870.KQ Pharos iBio Co., Ltd.
7,200.00
+0.56%
 
HEMO.L Hemogenyx Pharmaceuticals Plc
186.00
+0.40%
 
ADXN Addex Therapeutics Ltd
7.64
+8.61%
 
TCON TRACON Pharmaceuticals, Inc.
0.0322
0.00%